Letters to the Editor

Clinical and germline risk factors for multiple treatment-related toxicities in pediatric acute lymphoblastic leukemia

Kids Cancer Centre, Sydney Children’s Hospital Randwick, Sydney, Australia; Children’s Cancer Institute, Lowy Cancer Research Centre, UNSW, Sydney, Australia; Discipline of Paediatrics and Child Health, School of Clinical Medicine, UNSW Medicine and Health, UNSW Sydney, Australia; Northern Institute for Cancer Research, Wolfson Childhood Cancer Research Centre, Newcastle-Upon-Tyne
Children’s Cancer Institute, Lowy Cancer Research Centre, UNSW, Sydney, Australia; School of Clinical Medicine, UNSW Medicine and Health, UNSW Sydney, Kensington, NSW
Children’s Cancer Institute, Lowy Cancer Research Centre, UNSW, Sydney
Children’s Medical Research Institute, University of Sydney, Sydney, Australia; Department of Haematology, Queensland Children’s Hospital, Brisbane
QIMR Berghofer Medical Research Institute, Brisbane, Australia; Genetic Health Queensland, Royal Brisbane and Women's Hospital, Herston
Department of Clinical Haematology, Oncology, Blood and Marrow Transplantation, Perth Children’s Hospital, Perth
Children’s Cancer Institute, Lowy Cancer Research Centre, UNSW, Sydney, Australia; Discipline of Paediatrics and Child Health, School of Clinical Medicine, UNSW Medicine and Health, UNSW Sydney
Department of Haematology and Oncology, Women's and Children's Hospital, North Adelaide, Australia; University of Adelaide, North Adelaide, South Australia
Children’s Cancer Institute, Lowy Cancer Research Centre, UNSW, Sydney, Australia; Discipline of Paediatrics and Child Health, School of Clinical Medicine, UNSW Medicine and Health, UNSW Sydney
Kids Cancer Centre, Sydney Children’s Hospital Randwick, Sydney
John Hunter Children’s Hospital, Newcastle, Australia; University of Newcastle, Newcastle
Children’s Cancer Centre,The Royal Children’s Hospital, Melbourne, Australia; Department of paediatrics, University of Melbourne, Carlton, Australia; Pharmacogenomics team, Stem cell Medicine, Murdoch Children’s Research Institute, Parkville
Biospecimen Research Services, Children’s Cancer Research Unit, The Children’s Hospital at Westmead, Sydney
QIMR Berghofer Medical Research Institute, Brisbane
Department of Clinical Haematology, Oncology, Blood and Marrow Transplantation, Perth Children’s Hospital, Perth, Australia; Leukaemia Translational Research Laboratory, Telethon Kids Cancer Centre, Telethon Kids Institute, University of Western Australia, Perth, Australia; Curtin Medical School, Curtin University, Perth
Children’s Medical Research Institute, University of Sydney, Sydney, Australia; Cancer Centre for Children, The Children’s Hospital at Westmead, Sydney, Australia; Children’s Cancer Research Unit, The Children’s Hospital at Westmead, Sydney
Kids Cancer Centre, Sydney Children’s Hospital Randwick, Sydney, Australia; Children’s Cancer Institute, Lowy Cancer Research Centre, UNSW, Sydney, Australia; Discipline of Paediatrics and Child Health, School of Clinical Medicine, UNSW Medicine and Health, UNSW Sydney
Kids Cancer Centre, Sydney Children’s Hospital Randwick, Sydney, Australia; Children’s Cancer Institute, Lowy Cancer Research Centre, UNSW, Sydney, Australia; Discipline of Paediatrics and Child Health, School of Clinical Medicine, UNSW Medicine and Health, UNSW Sydney
Haematologica Early view Oct 30, 2025 https://doi.org/10.3324/haematol.2025.288939